Patient Guidance and Education of EGFR Inhibitor Therapies

Opinion
Video

Medical experts discuss strategies for educating patients on managing side effects of osimertinib and other EGFR inhibitors, with guidance on recognizing symptoms that warrant contacting their care team.

Video content above is prompted by the following:

  • How do you educate patients on potential side effects associated with osimertinib and other EGFR inhibitors?
  • What guidance do you provide on when they should reach out to their care team?
Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Related Content
© 2024 MJH Life Sciences

All rights reserved.